Pathways regulating plasmacytoid dendritic cells in Peyers Patches

派氏斑中浆细胞样树突状细胞的调节途径

基本信息

项目摘要

DESCRIPTION (provided by applicant): Plasmacytoid dendritic cells (pDCs) are principal type I interferon(IFN)-producing cells in bone marrow and lymphoid organs that are thought to play critical roles in anti-viral immunity. Upon activation through Toll-like receptors (TLRs), pDCs secrete IFN and mature to an antigen-presenting state in which they are able to elicit adaptive immune responses including CD4+ T cell polarization. The pDC developmental pathway proceeds through a common DC progenitor (CDP), which generates both pDCs and conventional DCs. PDC production depends on signaling by the receptor tyrosine kinase Flt3 and the transcription factors STAT3 and E2-2. A pDC subset was identified within Peyer's Patches (PP) in the gut that is unable to produce type I IFNs upon TLR triggering. This subset is implicated in oral tolerance; however the developmental origin and role for PP pDCs in eliciting adaptive immune responses are largely unknown. We found that PP pDC accrual required cell autonomous signaling via type I IFNs and STAT1, suggesting a distinct developmental or conditioning pathway compared to BM or splenic pDCs. Furthermore, we found that PP pDCs correlate with IL-17-secreting CD4+ T (Th17) cells in PPs. We hypothesize that PP pDCs arise from the same developmental pathway as pDCs localized in BM and spleen (i.e., via CDPs in response to Flt3-STAT3 signaling), however conditioning within the gut microenvironment may render distinct functional attributes including the ability to induce Th17 cell generation. We will test this hypothesis by investigating the pathways that regulate the accrual of pDCs within PPs (Aim 1). We will assess whether purified BM progenitors such as CDPs reconstitute PP pDCs in lethally irradiated mice or in a novel transplant model using Ifnar-/- animals that lack PP pDCs. Molecular pathways required for PP pDC generation will be examined by transplant experiments with BM progenitors from Stat1-/-, STAT3-deficient, Ifnar-/- or Tcf4-/- (E2-2-deficient) mice in steady state or in response to cytokines that elicit BM and spleen pDC generation (i.e., Flt3L, IFN-1). In Aim 2, we will determine whether PP pDCs are functionally distinct from BM or splenic pDCs in terms of eliciting CD4+ T cell responses, using in vitro CD4+ T cell polarization assays with purified PP, BM and splenic pDCs and naove CD4+ T cells. In addition, CD4+ T cell populations within PPs will be correlated with PP pDC reconstitution in Aim 1 to further examine the relationship between PP pDCs and Th cell responses, and the activation profiles of PP pDCs will be compared to BM and spleen pDCs by measuring candidate cytokine production, activating and inhibitory molecule expression and transcriptional profiles. Successful completion of this project will provide a mechanistic view of the PP pDC developmental pathway, and thus may contribute to development of therapeutic applications that enable redirection of the immune response in diseases associated with gastrointestinal inflammation.
描述(由申请人提供):浆细胞样树突状细胞(pDC)是骨髓和淋巴器官中主要的 I 型干扰素(IFN)产生细胞,被认为在抗病毒免疫中发挥关键作用。通过 Toll 样受体 (TLR) 激活后,pDC 会分泌 IFN 并成熟至抗原呈递状态,在该状态下它们能够引发适应性免疫反应,包括 CD4+ T 细胞极化。 pDC 发育途径通过共同 DC 祖细胞 (CDP) 进行,该祖细胞产生 pDC 和常规 DC。 PDC 的产生取决于受体酪氨酸激酶 Flt3 以及转录因子 STAT3 和 E2-2 的信号传导。在肠道派尔氏集结 (PP) 内鉴定出 pDC 子集,该子集在 TLR 触发时无法产生 I 型 IFN。该子集与口服耐受有关;然而,PP pDCs 的发育起源和在引发适应性免疫反应中的作用在很大程度上尚不清楚。我们发现 PP pDC 的生成需要通过 I 型 IFN 和 STAT1 的细胞自主信号传导,这表明与 BM 或脾 pDC 相比,存在独特的发育或调节途径。此外,我们发现 PP pDC 与 PP 中分泌 IL-17 的 CD4+ T (Th17) 细胞相关。我们假设 PP pDC 与位于 BM 和脾脏的 pDC 源自相同的发育途径(即通过 CDP 响应 Flt3-STAT3 信号传导),然而肠道微环境内的调节可能会呈现不同的功能属性,包括诱导 Th17 细胞生成的能力。我们将通过研究调节 PP 内 pDC 增长的途径来检验这一假设(目标 1)。我们将评估纯化的 BM 祖细胞(例如 CDP)是否可以在致命辐射小鼠中或在使用缺乏 PP pDC 的 Ifnar-/- 动物的新型移植模型中重建 PP pDC。 PP pDC 生成所需的分子途径将通过来自 Stat1-/-、STAT3 缺陷、Ifnar-/- 或 Tcf4-/-(E2-2 缺陷)小鼠的 BM 祖细胞移植实验进行检查,这些小鼠处于稳态或对诱导 BM 和脾 pDC 生成的细胞因子(即 Flt3L、IFN-1)作出反应。在目标 2 中,我们将使用纯化的 PP、BM 和脾 pDC 以及 naove CD4+ T 细胞进行体外 CD4+ T 细胞极化测定,确定 PP pDC 在引发 CD4+ T 细胞反应方面是否在功能上不同于 BM 或脾 pDC。此外,PP 内的 CD4+ T 细胞群将与目标 1 中的 PP pDC 重建相关,以进一步检查 PP pDC 和 Th 细胞反应之间的关系,并且通过测量候选细胞因子的产生、激活和抑制分子表达以及转录谱,将 PP pDC 的激活谱与 BM 和脾 pDC 进行比较。该项目的成功完成将提供 PP pDC 发育途径的机制观点,因此可能有助于开发治疗应用,从而能够重定向与胃肠道炎症相关的疾病的免疫反应。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Diversification of dendritic cell subsets: Emerging roles for STAT proteins.
  • DOI:
    10.4161/jkst.25112
  • 发表时间:
    2013-10-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Li HS;Watowich SS
  • 通讯作者:
    Watowich SS
Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephanie S Watowich其他文献

UBE2N Regulates Oncoprotein Networks in Myeloid Malignancies
  • DOI:
    10.1182/blood-2023-187438
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Chiharu Ishikawa;Laura Barreyro;Avery Sampson;Kathleen Hueneman;Kwangmin Choi;Lyndsey C. Bolanos;Andrew Volk;Stephanie S Watowich;Kenneth Greis;Daniel T. Starczynowski
  • 通讯作者:
    Daniel T. Starczynowski
STAT3 Protects Hematopoietic Stem and Progenitor Cell Function in Non-Inflamed Conditions
  • DOI:
    10.1182/blood-2022-170250
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Bhakti Patel;Yifan Zhou;Rachel L Babcock;Feiyang Ma;Yusra B Medik;Laura M Kahn;Josue E Pineda;Elizabeth Park;Karen Clise-Dwyer;Simona Colla;Stephanie S Watowich
  • 通讯作者:
    Stephanie S Watowich

Stephanie S Watowich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephanie S Watowich', 18)}}的其他基金

Regulation and function of nonlymphoid organ CD103+ dendritic cells
非淋巴器官CD103树突状细胞的调节和功能
  • 批准号:
    10469028
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
Development Research Program
发展研究计划
  • 批准号:
    10683958
  • 财政年份:
    2019
  • 资助金额:
    $ 19.75万
  • 项目类别:
Development Research Program
发展研究计划
  • 批准号:
    10415941
  • 财政年份:
    2019
  • 资助金额:
    $ 19.75万
  • 项目类别:
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
定义 STAT3 抗炎活性介导的造血细胞保护反应
  • 批准号:
    9906160
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
定义 STAT3 抗炎活性介导的造血细胞保护反应
  • 批准号:
    10393508
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
Regulation and function of nonlymphoid organ CD103 dendritic cells
非淋巴器官CD103树突状细胞的调节和功能
  • 批准号:
    8832406
  • 财政年份:
    2015
  • 资助金额:
    $ 19.75万
  • 项目类别:
Pathways regulating plasmacytoid dendritic cells in Peyers Patches
派氏斑中浆细胞样树突状细胞的调节途径
  • 批准号:
    8233828
  • 财政年份:
    2012
  • 资助金额:
    $ 19.75万
  • 项目类别:
Cytokine Regulation of Dendritic Cell Development
树突状细胞发育的细胞因子调节
  • 批准号:
    7240401
  • 财政年份:
    2007
  • 资助金额:
    $ 19.75万
  • 项目类别:
Cytokine Regulation of Dendritic Cell Development
树突状细胞发育的细胞因子调节
  • 批准号:
    7497558
  • 财政年份:
    2007
  • 资助金额:
    $ 19.75万
  • 项目类别:
MOLECULAR MECHANISMS CYTOKINE RECEPTOR SIGNALING
细胞因子受体信号转导的分子机制
  • 批准号:
    6173091
  • 财政年份:
    1998
  • 资助金额:
    $ 19.75万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了